Expansion, purification, and functional assessment of human peripheral blood NK cells

Journal of Visualized Experiments

Volumn , Issue 48, 2010, Pages

  Somanchi, Srinivas S ^a   Senyukov, Vladimir V ^a   Denman, Cecele J ^a   Lee, Dean A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Antigen Presenting Cells; Cytotoxicity; Immunology; Issue 48; Natural Killer Cells; Tumor Immunology

Indexed keywords

EID: 80055116109     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/2540     Document Type: Article

References (11)

1. McKenna, D. H. Jr., et al. Good manufacturing practices production of natural killer cells for immunotherapy: a six-year single-institution experience. Transfusion 47 (3), 520 (2007).
2. Koehl, U., et al. ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children. Klinische Padiatrie 217 (6), 345 (2005).
3. Klingemann, H. G. and Martinson, J., ex vivo expansion of natural killer cells for clinical applications. Cytotherapy 6 (1), 15 (2004).
4. Ayello, J., et al. Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivocellular engineering. Biol Blood Marrow Transplant 12 (6), 608 (2006)
5. Carlens, S. et al., A new method for in vitroexpansion of cytotoxic human CD3-CD56+ natural killer cells. Hum Immunol 62 (10), 1092 (2001).
6. Boissel, L., et al. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells. Biol Blood Marrow Transplant 14 (9), 1031 (2008).
7. North, J., et al. Tumor-primed human natural killer cells lyse NK-resistant tumor targets: evidence of a two-stage process in resting NK cell activation. J Immunol 178 (1), 85 (2007).
8. Berg, M., et al. Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells. Cytotherapy 11 (3), 341 (2009).
9. Fujisaki, H., et al. Expansion of highly cytotoxic human natural killer cells for cancer cell therapy. Cancer Res 69 (9), 4010 (2009).
10. Fujisaki, H., et al., Replicative potential of human natural killer cells. Br J Haematol 145 (5), 606 (2009).
11. Gong, W., et al. Ex vivo expansion of natural killer cells with high cytotoxicity by K562 cells modified to co-express major histocompatibility complex class I chain-related protein A, 4-1BB ligand, and interleukin-15. Tissue Antigens 76(6), 467 (2010).